Skip to main content
Log in

Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

KLK6 encoding kallikrein-related peptidase 6, a trypsin-like serine protease, has been shown to be upregulated in several cancers, although the tumorigenic role of KLK6 has not been elucidated. In this study, KLK6 was identified as a highly upregulated gene in gastric cancer; therefore, the possibility that KLK6 might be a suitable candidate tumor marker was examined. RT-PCR and immunohistochemical analysis showed overexpression of KLK6 in gastric cancer tissues compared to nontumor regions. Sera from gastric cancer patients had a 1.7-fold increase in KLK6 (373.1 μg/L, P = 0.048) compared to healthy individuals (214.2 μg/L), although there was no significant difference among patients with various tumor stages. Cellular invasiveness decreased by 45% in cells transfected with KLK6-specific small interfering RNA. Exogenous overexpression of KLK6 led to decreased activity of the E-cadherin promoter. This study shows that KLK6 is significantly upregulated and secreted in gastric cancer tissues and sera, suggesting that KLK6 might be used as a potential biomarker and therapeutic target for gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev. 2001;22:184–204.

    Article  PubMed  CAS  Google Scholar 

  2. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology. 1995;45:729–44.

    Article  PubMed  CAS  Google Scholar 

  3. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hk2) and prostate-specific antigen (psa): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci. 1998;35:275–368.

    Article  PubMed  CAS  Google Scholar 

  4. Stenman UH. New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hk2) as a marker for prostatic disease. Clin Chem. 1999;45:753–4.

    PubMed  CAS  Google Scholar 

  5. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4:876–90.

    Article  PubMed  CAS  Google Scholar 

  6. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G. Immunofluorometric assay of human kallikrein 6 (zyme/protease m/neurosin) and preliminary clinical applications. Clin Biochem. 2000;33:369–75.

    Article  PubMed  CAS  Google Scholar 

  7. Gan L, Lee I, Smith R, Argonza-Barrett R, Lei H, McCuaig J, Moss P, Paeper B, Wang K. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene. 2000;257:119–30.

    Article  PubMed  CAS  Google Scholar 

  8. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med. 1996;2:624–36.

    PubMed  CAS  Google Scholar 

  9. Little SP, Dixon EP, Norris F, Buckley W, Becker GW, Johnson M, Dobbins JR, Wyrick T, Miller JR, MacKellar W, Hepburn D, Corvalan J, McClure D, Liu X, Stephenson D, Clemens J, Johnstone EM. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J Biol Chem. 1997;272:25135–42.

    Article  PubMed  CAS  Google Scholar 

  10. Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T, Nakazato H, Yamaguchi N. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta. 1997;1350:11–4.

    PubMed  CAS  Google Scholar 

  11. Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP. Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 2004;25:193–9.

    Article  PubMed  CAS  Google Scholar 

  12. Paliouras M, Borgono C, Diamandis EP. Human tissue kallikreins: the cancer biomarker family. Cancer Lett. 2007;249:61–79.

    Article  PubMed  CAS  Google Scholar 

  13. Tanimoto H, Underwood LJ, Shigemasa K, Parmley TH, O'Brien TJ. Increased expression of protease m in ovarian tumors. Tumour Biol. 2001;22:11–8.

    Article  PubMed  CAS  Google Scholar 

  14. Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S. Rigault de la Longrais IA, Colgan T, Puopolo M, Giardina G, Massobrio M, Diamandis EP. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br J Cancer. 2002;87:763–71.

    Article  PubMed  CAS  Google Scholar 

  15. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M. Clinical significance of human kallikrein gene 6 messenger rna expression in colorectal cancer. Clin Cancer Res. 2005;11:2889–93.

    Article  PubMed  CAS  Google Scholar 

  16. Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Clin Cancer Res. 2005;11:3320–5.

    Article  PubMed  CAS  Google Scholar 

  17. Palmer HG, Sanchez-Carbayo M, Ordonez-Moran P, Larriba MJ, Cordon-Cardo C, Munoz A. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin d3 in human colon cancer cells. Cancer Res. 2003;63:7799–806.

    PubMed  CAS  Google Scholar 

  18. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, Sotiropoulou G, Diamandis EP, Hudson TJ, White JH. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002;16:1243–56.

    Article  PubMed  CAS  Google Scholar 

  19. Bayes A, Tsetsenis T, Ventura S, Vendrell J, Aviles FX, Sotiropoulou G. Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Biol Chem. 2004;385:517–24.

    Article  PubMed  CAS  Google Scholar 

  20. Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Cancer Res. 2009;69:3779–87.

    Article  PubMed  CAS  Google Scholar 

  21. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P. Human kallikrein 6 (zyme/protease m/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem. 2000;33:579–83.

    Article  PubMed  CAS  Google Scholar 

  22. Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Katsaros D. Human kallikrein 6 (hk6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J Clin Oncol. 2003;21:1035–43.

    Article  PubMed  CAS  Google Scholar 

  23. Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res. 2005;11:6800–6.

    Article  PubMed  CAS  Google Scholar 

  24. Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, Berkowitz RS, Ng SW. Characterisation of human kallikrein 6/protease m expression in ovarian cancer. Br J Cancer. 2004;91:725–31.

    PubMed  CAS  Google Scholar 

  25. Yousef GM, Borgono CA, Popalis C, Yacoub GM, Polymeris ME, Soosaipillai A, Diamandis EP. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers. Anticancer Res. 2004;24:43–51.

    PubMed  CAS  Google Scholar 

  26. Kim JT, Song EY, Chung KS, Kang MA, Kim JW, Kim SJ, Yeom YI, Kim JH, Kim KH, Lee HG. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer. 2011;117:2608–19.

    Article  PubMed  CAS  Google Scholar 

  27. Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP. Molecular characterization of zyme/protease m/neurosin (prss9), a hormonally regulated kallikrein-like serine protease. Genomics. 1999;62:251–9.

    Article  PubMed  CAS  Google Scholar 

  28. Luo LY, Soosaipillai A, Grass L, Diamandis EP. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Tumour Biol. 2006;27:227–34.

    Article  PubMed  CAS  Google Scholar 

  29. Henkhaus RS, Roy UK, Cavallo-Medved D, Sloane BF, Gerner EW, Ignatenko NA. Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Neoplasia. 2008;10:140–8.

    Article  PubMed  CAS  Google Scholar 

  30. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994;1198:11–26.

    PubMed  CAS  Google Scholar 

  31. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol. 1993;5:806–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Korea Ministry of Science and Technology (M1053608003-05 N3608-00310) and the High-tech Equipment for R&D in SMEs (S1071348) of Korea Technology and Information Promotion Agency for SMEs.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Pyung Keun Myung or Hee Gu Lee.

Additional information

Jin Ju Kim and Jong-Tae Kim contributed equally to the study

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, J.J., Kim, JT., Yoon, H.R. et al. Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer. Tumor Biol. 33, 731–738 (2012). https://doi.org/10.1007/s13277-011-0267-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-011-0267-1

Keywords

Navigation